Targeted therapy with MEK+CDK4/6 inhibitors

This moderated forum is to support the needs of patients with stage III melanoma, as well as to answer questions about treatment options and what to expect.

Targeted therapy with MEK+CDK4/6 inhibitors

Postby PWood » Sun Sep 24, 2017 9:30 pm

Hi: Is anyone involved in this trial: 'A phase I/II study of safety and efficiacy of ribociclib (LEE011) in combination with trametinib (TMT212) in subjects with advanced or metastatic solid tumours'? Trial number CTMT212X2106 or NCT02703571. My sister is considering participating so we would really appreciate hearing how you are getting on. She is Stage III, BRAF Wild Type, NRAS Q61. Thank you.
Posts: 14
Joined: Sat Jun 17, 2017 7:33 pm

Return to Melanoma: Stage III

Who is online

Registered users: Bing [Bot], Google [Bot]